FOXO1 and metabolic dysfunction-associated steatotic liver disease: In addition, AS1842856 attenuates necroptosis in NAFLD mice by specifically inhibiting Forkhead box O (FOXO1), a key downstream factor of the insulin/IGF-1 signaling pathway.